WEBINAR
Share:

Human-in-the-Loop (HITL) in GMP: Maintaining Human Oversight of AI-Assisted Decisions

  • Date
    16 September 2026
  • 11.00 AM Eastern Time (US/Canada)
    03.00 PM GMT

Course is now LIVE. Click below to join the session.

This course helps organizations establish meaningful human control over AI-assisted GMP decisions through risk-based review points, clear decision authority, traceable interventions, and lifecycle monitoring that supports accountable use of AI.

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
REGISTRATION OPTIONS

Live session Plus
Complimentary 30 Days Streaming access

$290  |  One participant (viewer)

$390  |  Team (2 - 5 participants)

$490 |  Team (6 - 10 participants)

REGISTER FOR THE COURSE

US $290 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $290 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Faculty
    Dr. Ginette Collazo
  • Duration
    60 Minutes
  • Course ID
    TF1309
  • Live Q&A +
    Post-live Continued Learning
  • Presentation Handout
    & Templates
  • Assessment
    & Certification Included

 

Why take this course?

As artificial intelligence becomes integrated into GMP operations, organizations need defined controls for where human judgment enters AI-assisted decision processes. Human-in-the-Loop (HITL) establishes intervention points where qualified personnel review, challenge, approve, reject, or override AI-generated recommendations. Effective oversight requires more than human presence; decision authority, responsibilities, escalation criteria, documentation, and traceability must be established according to the risk associated with the AI-supported activity.


This webinar examines how HITL controls can support data integrity, risk management, validation, and inspection readiness throughout the AI system lifecycle. Participants will consider when human review is necessary, how overrides should be governed, what records should connect AI outputs with final decisions, and how audit trails can support reconstruction of significant actions. The discussion also addresses ongoing monitoring of AI performance, deviations, unexpected outputs, override trends, and reassessment of human controls when systems, data, intended use, or risk changes.

Determine Where Human Intervention Is Necessary

Develop a risk-based basis for deciding which AI outputs require human review, approval, challenge, or escalation. Clear intervention criteria help qualified personnel retain appropriate control over higher-risk decisions while avoiding the assumption that simply placing a person within an AI-supported process constitutes effective oversight.

Create Evidence of Meaningful Human Oversight

Strengthen the records connecting AI outputs, human reviews, approvals, changes, and overrides to final GMP decisions. Inspection-ready evidence should show who reviewed an output, what information was considered, when intervention occurred, what decision followed, and how AI performance and human controls continue to be assessed over time.

Key Areas Covered

  • Human-in-the-Loop principles within GMP operations
  • Risk-based human review and approval criteria
  • Authority to challenge, reject, or override AI recommendations
  • Escalation criteria for uncertain or abnormal AI outputs
  • Traceability between AI outputs and final human decisions
  • Audit trails supporting reconstruction of significant decisions
  • Lifecycle monitoring of deviations, overrides, and performance trends
  • Inspection-ready evidence of effective human oversight

Who Must Attend

  • Quality Assurance Departments
  • Quality Control Departments
  • Validation and Computer System Validation personnel
  • Manufacturing Departments
  • Operations Departments
  • Data Integrity professionals
  • Regulatory Affairs Departments
  • IT and Digital Transformation teams
  • AI/ML system owners
  • Compliance and auditing personnel
Meredith Crabtree
COURSE DIRECTOR

Dr. Ginette Collazo

Dr. Ginette Collazo has over 20 years of experience in Industrial-Organizational Psychology specializing in GMP manufacturing, human performance, critical thinking, human error reduction, and root cause analysis. Her work examining human behavior and workplace decision-making directly supports the human judgment, intervention authority, accountability, and oversight considerations central to Human-in-the-Loop controls in GMP environments.

If you would like to request a Proforma invoice to sign up for this course. please click here

Commonly Asked Questions About This Subject

The following questions address practical regulatory, compliance, validation, quality, operational, and inspection-related considerations commonly associated with this subject.

How can an organization demonstrate that human review of AI output is genuinely independent rather than a routine approval step?

A reviewer needs enough information, authority, and technical competence to reach a different conclusion from the AI system. If personnel routinely approve recommendations without examining the underlying evidence, human review can become little more than an electronic signature.


This weakness often appears gradually. As users gain confidence in a system, review times shorten, acceptance rates increase, and explanations become standardized. Those patterns do not prove inadequate oversight, but they deserve attention when the human decision is intended to function as a meaningful control.


Evidence of effective review can include instances where personnel requested additional information, identified questionable inputs, corrected outputs, escalated uncertainty, or rejected recommendations. The organization should also be able to explain what reviewers are expected to examine before accepting an output.


During inspection, records showing thoughtful intervention can carry considerably more weight than thousands of approvals that provide no evidence of what the reviewer actually evaluated.

What should happen when human reviewers almost never override an AI system?

A very low override rate deserves evaluation rather than automatic interpretation as evidence that the AI system is performing exceptionally well. The organization should determine whether the system is genuinely producing reliable recommendations or whether users have gradually become reluctant to challenge it.


The distinction can be tested. Review selected accepted decisions retrospectively and ask qualified personnel to assess the underlying evidence without relying on the original AI recommendation. Examine whether unusual outputs received deeper review, whether users understand known system limitations, and whether disagreement rates differ significantly between departments, sites, or experience levels.


Inspection friction develops when personnel are described as an important safeguard but records show near universal acceptance with little evidence of independent assessment.


Low override rates can be entirely appropriate. The defensible position comes from demonstrating why they are low and showing that personnel remain capable and willing to intervene when the recommendation does not withstand technical or quality scrutiny.

How should human oversight be handled when AI output is technically correct but based on incomplete or poor-quality input data?

The decision should be stopped or qualified when the input data cannot support the intended GMP conclusion. A technically functioning model cannot compensate for missing, outdated, incorrectly mapped, or contextually misleading information.


This becomes particularly important with systems drawing information from multiple sources. An AI recommendation may appear coherent while relying on an incomplete deviation history, an incorrect equipment identifier, missing laboratory results, or data captured before a relevant process change. The output itself may provide little indication that important context is absent.


Human oversight therefore needs to include attention to input sufficiency where the risk warrants it. Reviewers should understand which source information materially affects the decision and recognize circumstances where additional verification is necessary.


If a significant decision is later questioned, "the AI processed the available data correctly" provides a weak defense when the organization had no effective control for determining whether the available data were adequate in the first place.

When can Human-in-the-Loop controls become weaker over time even though procedures and approval workflows have not changed?

Oversight can deteriorate through familiarity, workload pressure, increasing confidence in the system, staff turnover, or gradual expansion of how the AI is used. None of those changes necessarily alters the formal approval workflow, which is why declining effectiveness can remain unnoticed.


An operational warning sign is when the original review expectations no longer match actual practice. Users may begin relying on summarized outputs instead of source information, reviews may become faster, exceptions may receive less scrutiny, or the system may start supporting decisions beyond the conditions originally evaluated.


Periodic assessment should therefore examine actual reviewer behavior and decision quality, not simply confirm that required approvals occurred. Useful evidence includes review depth, intervention patterns, recurring errors, near misses, user feedback, and cases where additional investigation changed the initial recommendation.


A stable procedure does not demonstrate stable oversight. Effective HITL controls need evidence that human involvement continues to provide the level of scrutiny the control was designed to achieve.

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation

You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can join the session, access materials, and manage your learning.

3. Join the Live Training
At the scheduled time, click Join Session and you’ll be connected to the live Webex session with the instructor.

4. Watch Again Anytime
After the session, the playback becomes available on the same course page so you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

Everything related to your webinar: access, materials, playback, and certification — lives in one place.
Simple. Organized. Professional.
Go ahead and reserve your seat with confidence.

Built on 20+ years of global regulatory training experience across FDA, EMA, MHRA, and ICH frameworks.
Trusted by professionals across 80+ countries.

Testimonials

This is an upcoming session. Feedback below reflects experiences from similar programs delivered by our expert faculty.

“Session was easy to follow even for non-core team members. That helped.”
- Production Officer
“Good balance. Not too basic, not too deep. Worked well for mixed team.”
- Manager, Regulatory Affairs
“Team found it useful. Especially for aligning understanding across functions.”
- Director, Operations

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Featured Courses